再论特发性肺纤维化的药物治疗

万方数据

万方数据

再论特发性肺纤维化的药物治疗

作者：徐作军

作者单位：100730,中国医学科学院北京协和医院呼吸内科

刊名：

中华结核和呼吸杂志

英文刊名：Chinese Journal of Tuberculosis and Respiratory Diseases

年，卷(期)：2014,37(9)

参考文献(10条)

1.Rahgu G;Collard HR;Egan J J An Official ATS/ERS/ JRS/ALAT Statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management 2011

2.American Thoracic Society (ATS);the European Respiratory Society (ERS)Idiopathic pulmonary fibrosis:diagnosis and treatment.International consensus statement 2000

3.American Thoracic Society (ATS);The European Respiratory Society (ERS)American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias 2002

4.Raghu G;Anstrom K J;King TE Jr Prednisone,azathioprine,and N-acetylcysteine for pulmonary fibrosis 2012

5.Martinez FJ;Andrade JA de;Anstrom KJ Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis 2014

6.Noth I;Anstrom KJ;Calvert SB A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis 2012

7.Taniguchi H;Ebina M;Kondoh Y Pirfenidone clinical study group in Japan.Pirfenidone in idiopathic pulmonary fibrosis 2010(04)

8.Noble PW;Albera C;Bradford WZ Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY):two randomized trials 2011

9.King TE;Bradford WZ;Castro-Bernardini S A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis 2014

10.Richeldi L;du Bois RM;Raghu G Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis 2014

引用本文格式：徐作军再论特发性肺纤维化的药物治疗[期刊论文]-中华结核和呼吸杂志 2014(9)